Quest Partners LLC Has $321,000 Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Quest Partners LLC cut its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 46.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,971 shares of the health services provider’s stock after selling 30,792 shares during the quarter. Quest Partners LLC’s holdings in Teladoc Health were worth $321,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Teladoc Health by 2.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock worth $641,000 after acquiring an additional 1,352 shares during the period. Signaturefd LLC boosted its position in Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares during the period. Blue Trust Inc. boosted its position in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after acquiring an additional 1,854 shares during the period. Arizona State Retirement System boosted its position in Teladoc Health by 4.2% during the 2nd quarter. Arizona State Retirement System now owns 47,400 shares of the health services provider’s stock worth $464,000 after acquiring an additional 1,901 shares during the period. Finally, Gabelli Funds LLC boosted its position in Teladoc Health by 10.1% during the 1st quarter. Gabelli Funds LLC now owns 22,970 shares of the health services provider’s stock worth $347,000 after acquiring an additional 2,100 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on TDOC. Royal Bank of Canada lifted their price target on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a report on Wednesday, October 9th. Cantor Fitzgerald reiterated an “overweight” rating and set a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th. Piper Sandler reduced their price target on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Truist Financial reduced their price target on Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $12.02 on Tuesday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $9.18 and its two-hundred day moving average is $9.25. The company has a market cap of $2.07 billion, a P/E ratio of -2.08 and a beta of 0.90. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $22.54.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Mala Murthy sold 8,750 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now directly owns 85,767 shares in the company, valued at approximately $614,091.72. The trade was a 9.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Michael Willem Waters sold 4,218 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the sale, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. This represents a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,051 shares of company stock valued at $143,565 in the last three months. Company insiders own 0.95% of the company’s stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.